Primaarin ja sekundaarisen hypertension hemodynamiikka: DYNAMIC–tutkimus - DYNAMIC

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-002065-39-FI

Enrollment

1000

Registered

2006-05-05

Start date

2006-05-24

Completion date

Unknown

Last updated

2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Terveet vaapaaehtoiset Primaari hypertensio Sekundaari hypertensio Munuaisten vajaatoiminta Ateroskleroottinen valtimosairaus

Interventions

Trade Name: Nitro Pharmaceutical Form: Sublingual tablet INN or Proposed INN: glyseryylitrinitraatti Pharmaceutical form of the placebo: Sublingual tablet Route of administration of the placebo: Subli

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Mar 7, 2026